isomethyleugenol has been researched along with Rubinstein-Taybi Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gamu, D; Gibson, WT | 1 |
| Kim, Y; Kowall, NW; Lee, J; Park, E; Ryu, H | 1 |
| Kundu, TK; Reddy, BA; Ruthrotha Selvi, B; Sukanya, MS; Swaminathan, V | 1 |
2 review(s) available for isomethyleugenol and Rubinstein-Taybi Syndrome
| Article | Year |
|---|---|
Reciprocal skeletal phenotypes of PRC2-related overgrowth and Rubinstein-Taybi syndromes: potential role of H3K27 modifications.
Topics: Acylation; Animals; Disease Models, Animal; Histones; Humans; Lysine; Methylation; Mice; Polycomb-Group Proteins; Rubinstein-Taybi Syndrome | 2020 |
Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Topics: Acetylation; Animals; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Carriers; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Neoplasms; Phosphorylation; Protamine Kinase; Protein Processing, Post-Translational; Rubinstein-Taybi Syndrome | 2007 |
1 other study(ies) available for isomethyleugenol and Rubinstein-Taybi Syndrome
| Article | Year |
|---|---|
Epigenetic mechanisms of Rubinstein-Taybi syndrome.
Topics: Acetylation; Animals; Chromatin; CREB-Binding Protein; Disease Models, Animal; Epigenesis, Genetic; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; MicroRNAs; Models, Biological; Mutation; p300-CBP Transcription Factors; Protein Processing, Post-Translational; Rubinstein-Taybi Syndrome; Sequence Deletion; Tumor Suppressor Protein p53 | 2014 |